Skip to main content
NIH funding notice PAR-18-853

Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)

Closed on November 27, 2020.

Posted
July 10, 2018
Close date
November 27, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $873,611 in first-year total cost, median $436,806.

Most frequent study sections

  1. Cellular, Molecular and Integrative Reproduction Study Section[CMIR]1
  2. Special Emphasis Panel[ZRG1 EMNR-P (56)]1

Most frequent institutions

  1. BAYLOR COLLEGE OF MEDICINE1
  2. UNIVERSITY OF MINNESOTA1
Competing awards under PAR-18-853 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Development/Validation of Rete Testis Microcannulation for the Assessment of Novel Chemical Scaffolds That Penetrate the Blood Testis Barrier1R61HD103065-01A1HAMRA, F. KENTWONG, HENRY LUNIVERSITY OF MINNESOTA, MN$437,153CMIR
2020Elucidating Chemical Features that Block or Facilitate Passage across the Blood-Testis and/or Blood-Epidydimal Barriers in Mice1R61HD099995-01LI, FENGBAYLOR COLLEGE OF MEDICINE, TX$436,458ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.